152 related articles for article (PubMed ID: 18694758)
1. Molecular basis of recognition of human osteopontin by 23C3, a potential therapeutic antibody for treatment of rheumatoid arthritis.
Du J; Hou S; Zhong C; Lai Z; Yang H; Dai J; Zhang D; Wang H; Guo Y; Ding J
J Mol Biol; 2008 Oct; 382(4):835-42. PubMed ID: 18694758
[TBL] [Abstract][Full Text] [Related]
2. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells.
Fan K; Dai J; Wang H; Wei H; Cao Z; Hou S; Qian W; Wang H; Li B; Zhao J; Xu H; Yang C; Guo Y
Arthritis Rheum; 2008 Jul; 58(7):2041-52. PubMed ID: 18576331
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for the recognition of CCN1 by monoclonal antibody 093G9.
Zhong C; Huo R; Hu K; Shen J; Li D; Li N; Ding J
J Mol Recognit; 2017 Nov; 30(11):. PubMed ID: 28608634
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of a human autoimmune complex between IgM rheumatoid factor RF61 and IgG1 Fc reveals a novel epitope and evidence for affinity maturation.
Duquerroy S; Stura EA; Bressanelli S; Fabiane SM; Vaney MC; Beale D; Hamon M; Casali P; Rey FA; Sutton BJ; Taussig MJ
J Mol Biol; 2007 May; 368(5):1321-31. PubMed ID: 17395205
[TBL] [Abstract][Full Text] [Related]
5. A humanized anti-osteopontin antibody protects from Concanavalin A induced-liver injury in mice.
Fan K; Zhang B; Yang H; Wang H; Tan M; Hou S; Qian W; Li B; Wang H; Dai J; Guo Y
Eur J Pharmacol; 2011 Apr; 657(1-3):144-51. PubMed ID: 21300057
[TBL] [Abstract][Full Text] [Related]
6. Structure of anti-FLAG M2 Fab domain and its use in the stabilization of engineered membrane proteins.
Roosild TP; Castronovo S; Choe S
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Sep; 62(Pt 9):835-9. PubMed ID: 16946459
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of chimeric antibody C2H7 Fab in complex with a CD20 peptide.
Du J; Wang H; Zhong C; Peng B; Zhang M; Li B; Hou S; Guo Y; Ding J
Mol Immunol; 2008 May; 45(10):2861-8. PubMed ID: 18346788
[TBL] [Abstract][Full Text] [Related]
8. The crystal structure of the pathogenic collagen type II-specific mouse monoclonal antibody CIIC1 Fab: structure to function analysis.
Uysal H; Sehnert B; Nandakumar KS; Böiers U; Burkhardt H; Holmdahl R; Thunnissen MM
Mol Immunol; 2008 Apr; 45(8):2196-204. PubMed ID: 18241923
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
Li Y; Li H; Smith-Gill SJ; Mariuzza RA
Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
[TBL] [Abstract][Full Text] [Related]
10. The Combining Sites of Anti-lipid A Antibodies Reveal a Widely Utilized Motif Specific for Negatively Charged Groups.
Haji-Ghassemi O; Müller-Loennies S; Rodriguez T; Brade L; Grimmecke HD; Brade H; Evans SV
J Biol Chem; 2016 May; 291(19):10104-18. PubMed ID: 26933033
[TBL] [Abstract][Full Text] [Related]
11. Structure of the Fab fragment of therapeutic antibody Ofatumumab provides insights into the recognition mechanism with CD20.
Du J; Yang H; Guo Y; Ding J
Mol Immunol; 2009 Jul; 46(11-12):2419-23. PubMed ID: 19427037
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of an anti-interleukin-2 monoclonal antibody Fab complexed with an antigenic nonapeptide.
Afonin PV; Fokin AV; Tsygannik IN; Mikhailova IY; Onoprienko LV; Mikhaleva II; Ivanov VT; Mareeva TY; Nesmeyanov VA; Li N; Pangborn WA; Duax WL; Pletnev VZ
Protein Sci; 2001 Aug; 10(8):1514-21. PubMed ID: 11468348
[TBL] [Abstract][Full Text] [Related]
13. Unusual water-mediated antigenic recognition of the proinflammatory cytokine interleukin-18.
Argiriadi MA; Xiang T; Wu C; Ghayur T; Borhani DW
J Biol Chem; 2009 Sep; 284(36):24478-89. PubMed ID: 19553661
[TBL] [Abstract][Full Text] [Related]
14. VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface.
Muller YA; Chen Y; Christinger HW; Li B; Cunningham BC; Lowman HB; de Vos AM
Structure; 1998 Sep; 6(9):1153-67. PubMed ID: 9753694
[TBL] [Abstract][Full Text] [Related]
15. Human-engineered monoclonal antibodies retain full specific binding activity by preserving non-CDR complementarity-modulating residues.
Studnicka GM; Soares S; Better M; Williams RE; Nadell R; Horwitz AH
Protein Eng; 1994 Jun; 7(6):805-14. PubMed ID: 7937712
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of collagen-induced arthritis in non-human primates by chimeric anti-osteopontin antibody.
Yamamoto N; Nakashima T; Torikai M; Naruse T; Morimoto J; Kon S; Sakai F; Uede T
Int Immunopharmacol; 2007 Nov; 7(11):1460-70. PubMed ID: 17761350
[TBL] [Abstract][Full Text] [Related]
17. Complex of a protective antibody with its Ebola virus GP peptide epitope: unusual features of a V lambda x light chain.
Lee JE; Kuehne A; Abelson DM; Fusco ML; Hart MK; Saphire EO
J Mol Biol; 2008 Jan; 375(1):202-16. PubMed ID: 18005986
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for recognition of CD20 by therapeutic antibody Rituximab.
Du J; Wang H; Zhong C; Peng B; Zhang M; Li B; Huo S; Guo Y; Ding J
J Biol Chem; 2007 May; 282(20):15073-80. PubMed ID: 17395584
[TBL] [Abstract][Full Text] [Related]
19. Stabilization of antibody structure upon association to a human carbonic anhydrase IX epitope studied by X-ray crystallography, microcalorimetry, and molecular dynamics simulations.
Král V; Mader P; Collard R; Fábry M; Horejsí M; Rezácová P; Kozísek M; Závada J; Sedlácek J; Rulísek L; Brynda J
Proteins; 2008 May; 71(3):1275-87. PubMed ID: 18041760
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal antibody recognition of a PorA epitope of Neisseria meningitidis: crystal structure of a Fab fragment in complex with a fluorescein-conjugated peptide.
van den Elsen JM; Herron JN; Hoogerhout P; Poolman JT; Boel E; Logtenberg T; Wilting J; Crommelin DJ; Kroon J; Gros P
Proteins; 1997 Sep; 29(1):113-25. PubMed ID: 9294871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
